Ameya Dravid is a postdoctoral researcher in Ankur Singh’s lab at Georgia Tech. In this postdoc portrait article, he ...

Two distinct subtypes, U-CLL C1 and U-CLL C2, were identified within IGHV-unmutated chronic lymphocytic leukemia, showing ...

The mechanism underlying how seasonal allergies recur year after year with precise timing remains largely unknown. An international team led by Professor Rudolf Valenta has identified a specific type ...

Patients were randomly assigned on a 1:1 basis to receive teclistamab as monotherapy or physician’s choice of ...

Gut health, antibiotic resistance, probiotics and the effects of bacteria on the immune system are specialties for Amir Mani, a new faculty member in the Department of Animal Science for the Arkansas ...

Blood donation is often called the “gift of life,” yet for a country that needs blood every single day, hesitation and ...

Orphai Therapeutics Inc. ("Orphai"), a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant unmet need, today announced that ...

Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of ...

Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...

All patients with autoimmune hemolytic anemia in a small study initially achieved remission, though two eventually relapsed, ...

We report a rare case of acute neurological Behçet’s disease (neuro-BD) diagnosed concurrently with systemic Behçet’s disease ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...